Wei RL - Search Results

1

[Pharmacovigilance guidelines for clinical application of oral Chinese patent medicines].

Wang LX, Yang S, Wei RL, Li YY, Cui X, Zhao XX, Peng WX, Liu FM, Wang MM, Li XH, Wang ZF, Xie YM. Wang LX, et al. Among authors: wei rl. Zhongguo Zhong Yao Za Zhi. 2024 Aug;49(16):4273-4278. doi: 10.19540/j.cnki.cjcmm.20240517.501. Zhongguo Zhong Yao Za Zhi. 2024. PMID: 39307763 Chinese.

2

[Post-marketing surveillance on Guizhi Fuling Jiaonang based on literature review].

Wang GQ, Gao Y, Liu FM, Wei RL, Xie YM. Wang GQ, et al. Among authors: wei rl. Zhongguo Zhong Yao Za Zhi. 2018 Feb;43(4):820-832. doi: 10.19540/j.cnki.cjcmm.20180126.002. Zhongguo Zhong Yao Za Zhi. 2018. PMID: 29600661 Review. Chinese.

3

[Analysis on 1 500 adverse reactions of Guizhi Fuling Capsules based on spontaneous response system].

Wei RL, Xie YM, Zhang WL. Wei RL, et al. Zhongguo Zhong Yao Za Zhi. 2019 Apr;44(7):1497-1502. doi: 10.19540/j.cnki.cjcmm.20181219.001. Zhongguo Zhong Yao Za Zhi. 2019. PMID: 31090310 Chinese.

4

[Analysis of Qingkailing Injection in treatment of combined medication features of 2 147 cases of upper respiratory tract infection].

Zhao SC, Wei RL, Xie YM, Wang LX, Wang Q, Yi DH. Zhao SC, et al. Among authors: wei rl. Zhongguo Zhong Yao Za Zhi. 2019 Dec;44(23):5207-5216. doi: 10.19540/j.cnki.cjcmm.20191115.501. Zhongguo Zhong Yao Za Zhi. 2019. PMID: 32237359 Chinese.

5

[Study of integrative evidence chain in clinical trial of Guizhi Fuling Capsules based on "Yibing Tongzhi" in clinical applications].

Gao Y, Wang GQ, Xie YM, Wei RL, Liu FM. Gao Y, et al. Among authors: wei rl. Zhongguo Zhong Yao Za Zhi. 2020 May;45(10):2304-2309. doi: 10.19540/j.cnki.cjcmm.20200211.504. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 32495585 Chinese.

6

[Cognition of traditional Chinese medicine properties and thinking of clinical rational use of drug].

Wei RL, Wang LX, Xie YM. Wei RL, et al. Zhongguo Zhong Yao Za Zhi. 2021 Nov;46(21):5462-5467. doi: 10.19540/j.cnki.cjcmm.20210330.501. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 34951197 Chinese.

7

[Report standards for clinical comprehensive evaluation of Chinese patent medicine].

Zhang Q, Wang ZF, Xie YM, Li YY, Wang LX, Liu H, Geng HJ, Cui X, Liu FM, Sun CQ, Wei RL, Zhang LD. Zhang Q, et al. Among authors: wei rl. Zhongguo Zhong Yao Za Zhi. 2021 Dec;46(23):6062-6067. doi: 10.19540/j.cnki.cjcmm.20210930.502. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 34951233 Chinese.

8

[Clinical comprehensive evaluation of Wenxin Granules in treatment of arrhythmia with deficiency of Qi and Yin].

Wei RL, Wang ZF, Ma XC, Zhang Q, Cui X, Xie YM. Wei RL, et al. Zhongguo Zhong Yao Za Zhi. 2021 Dec;46(23):6068-6077. doi: 10.19540/j.cnki.cjcmm.20210930.503. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 34951234 Chinese.

9

[Pharmacoeconomic evaluation of Qidong Yixin Oral Liquid in treatment of viral myocarditis (Qi-Yin deficiency syndrome) with TreeAge Pro].

Wei RL, Cui X, Xie YM. Wei RL, et al. Zhongguo Zhong Yao Za Zhi. 2022 Feb;47(3):829-835. doi: 10.19540/j.cnki.cjcmm.20211115.501. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 35178966 Chinese.

10

[Pharmacovigilance guidelines of Chinese patent medicines].

Wang LX, Wang MM, Li YY, Wang ZF, Cui X, Zhao XX, Liu FM, Yang S, Wei RL, Wang YX, Zhang B, Xie YM. Wang LX, et al. Among authors: wei rl. Zhongguo Zhong Yao Za Zhi. 2024 Aug;49(16):4261-4265. doi: 10.19540/j.cnki.cjcmm.20240623.501. Zhongguo Zhong Yao Za Zhi. 2024. PMID: 39307761 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters